291 related articles for article (PubMed ID: 28108629)
1. Myeloid STAT3 Promotes Lung Tumorigenesis by Transforming Tumor Immunosurveillance into Tumor-Promoting Inflammation.
Zhou J; Qu Z; Sun F; Han L; Li L; Yan S; Stabile LP; Chen LF; Siegfried JM; Xiao G
Cancer Immunol Res; 2017 Mar; 5(3):257-268. PubMed ID: 28108629
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy.
Lu B; Yang M; Wang Q
J Mol Med (Berl); 2016 May; 94(5):535-43. PubMed ID: 26922618
[TBL] [Abstract][Full Text] [Related]
3. Stat6 Promotes Intestinal Tumorigenesis in a Mouse Model of Adenomatous Polyposis by Expansion of MDSCs and Inhibition of Cytotoxic CD8 Response.
Jayakumar A; Bothwell ALM
Neoplasia; 2017 Aug; 19(8):595-605. PubMed ID: 28654863
[TBL] [Abstract][Full Text] [Related]
4. IL22 Promotes
Khosravi N; Caetano MS; Cumpian AM; Unver N; De la Garza Ramos C; Noble O; Daliri S; Hernandez BJ; Gutierrez BA; Evans SE; Hanash S; Alekseev AM; Yang Y; Chang SH; Nurieva R; Kadara H; Chen J; Ostrin EJ; Moghaddam SJ
Cancer Immunol Res; 2018 Jul; 6(7):788-797. PubMed ID: 29764837
[TBL] [Abstract][Full Text] [Related]
5. Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models.
Sahraei M; Bose M; Sanders JA; De C; DasRoy L; Nath S; Brouwer CR; Mukherjee P
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070449
[TBL] [Abstract][Full Text] [Related]
6. Signal transducer and activator of transcription 3 (Stat3C) promotes myeloid-derived suppressor cell expansion and immune suppression during lung tumorigenesis.
Wu L; Du H; Li Y; Qu P; Yan C
Am J Pathol; 2011 Oct; 179(4):2131-41. PubMed ID: 21864492
[TBL] [Abstract][Full Text] [Related]
7. STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis.
Yue C; Shen S; Deng J; Priceman SJ; Li W; Huang A; Yu H
Cancer Immunol Res; 2015 Aug; 3(8):864-870. PubMed ID: 26025380
[TBL] [Abstract][Full Text] [Related]
8. Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment.
Kuo IY; Yang YE; Yang PS; Tsai YJ; Tzeng HT; Cheng HC; Kuo WT; Su WC; Chang CP; Wang YC
Theranostics; 2021; 11(14):7029-7044. PubMed ID: 34093869
[No Abstract] [Full Text] [Related]
9. SOCS3 Deficiency in Myeloid Cells Promotes Tumor Development: Involvement of STAT3 Activation and Myeloid-Derived Suppressor Cells.
Yu H; Liu Y; McFarland BC; Deshane JS; Hurst DR; Ponnazhagan S; Benveniste EN; Qin H
Cancer Immunol Res; 2015 Jul; 3(7):727-40. PubMed ID: 25649351
[TBL] [Abstract][Full Text] [Related]
10. Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression.
Zhang M; Liu Q; Mi S; Liang X; Zhang Z; Su X; Liu J; Chen Y; Wang M; Zhang Y; Guo F; Zhang Z; Yang R
J Immunol; 2011 Apr; 186(8):4716-24. PubMed ID: 21383238
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of PPARγ in myeloid-lineage cells induces systemic inflammation, immunosuppression, and tumorigenesis.
Wu L; Yan C; Czader M; Foreman O; Blum JS; Kapur R; Du H
Blood; 2012 Jan; 119(1):115-26. PubMed ID: 22053106
[TBL] [Abstract][Full Text] [Related]
12. Attenuated Toxoplasma gondii Stimulates Immunity to Pancreatic Cancer by Manipulation of Myeloid Cell Populations.
Sanders KL; Fox BA; Bzik DJ
Cancer Immunol Res; 2015 Aug; 3(8):891-901. PubMed ID: 25804437
[TBL] [Abstract][Full Text] [Related]
13. Targeted STAT3 disruption in myeloid cells alters immunosuppressor cell abundance in a murine model of spontaneous medulloblastoma.
Abad C; Nobuta H; Li J; Kasai A; Yong WH; Waschek JA
J Leukoc Biol; 2014 Feb; 95(2):357-67. PubMed ID: 24068730
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory roles of signal transducer and activator of transcription 3 in antitumor immunity during carcinogen-induced lung tumorigenesis.
Ihara S; Kida H; Arase H; Tripathi LP; Chen YA; Kimura T; Yoshida M; Kashiwa Y; Hirata H; Fukamizu R; Inoue R; Hasegawa K; Goya S; Takahashi R; Minami T; Tsujino K; Suzuki M; Kohmo S; Inoue K; Nagatomo I; Takeda Y; Kijima T; Mizuguchi K; Tachibana I; Kumanogoh A
Cancer Res; 2012 Jun; 72(12):2990-9. PubMed ID: 22659452
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.
Thorn M; Guha P; Cunetta M; Espat NJ; Miller G; Junghans RP; Katz SC
Cancer Gene Ther; 2016 Jun; 23(6):188-98. PubMed ID: 27199222
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
[TBL] [Abstract][Full Text] [Related]
17. STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers.
Moreira D; Adamus T; Zhao X; Su YL; Zhang Z; White SV; Swiderski P; Lu X; DePinho RA; Pal SK; Kortylewski M
Clin Cancer Res; 2018 Dec; 24(23):5948-5962. PubMed ID: 30337279
[TBL] [Abstract][Full Text] [Related]
18. Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte function.
Chen EP; Markosyan N; Connolly E; Lawson JA; Li X; Grant GR; Grosser T; FitzGerald GA; Smyth EM
Carcinogenesis; 2014 Aug; 35(8):1788-97. PubMed ID: 24590894
[TBL] [Abstract][Full Text] [Related]
19. IL6/STAT3 Signaling Orchestrates Premetastatic Niche Formation and Immunosuppressive Traits in Lung.
Jing B; Wang T; Sun B; Xu J; Xu D; Liao Y; Song H; Guo W; Li K; Hu M; Zhang S; Ling J; Kuang Y; Zhang T; Zhou BP; Yao F; Deng J
Cancer Res; 2020 Feb; 80(4):784-797. PubMed ID: 31848193
[TBL] [Abstract][Full Text] [Related]
20. Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization.
Barberi T; Martin A; Suresh R; Barakat DJ; Harris-Bookman S; Drake CG; Lim M; Friedman AD
Cancer Immunol Immunother; 2018 Oct; 67(10):1491-1503. PubMed ID: 30030559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
